articleClinical Gastroenterology and HepatologyJun 1, 2006Closed access

A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease

HBHenri BraatPRPieter RottiersDWDaniël W. HommesNHNathalie HuyghebaertERErik Remaut

Academic Medical Center · Vlaams Instituut voor Biotechnologie · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

766
total citations
FWCI
38.18
Percentile
100%
References
22
Citations per year

Authors

10

Topics & keywords

Topics
Keywords
  • Genetically modified organism
  • Medicine
  • Adverse effect
  • Lactococcus lactis
  • Bacteria
  • Disease
  • Transgene
  • Crohn's disease
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.